SOURCE: Bederra Corp.

June 11, 2009 09:55 ET

Bederra Corporation in Talks to Acquire Neogenex Medical Technologies, Inc.

HOUSTON, TX--(Marketwire - June 11, 2009) - Bederra Corporation (PINKSHEETS: BEDA), a Houston, Texas-based diversified medical services provider is currently in talks to acquire Neogenex Medical Technologies, Inc; a company that provides laser technology equipment used in Pain Management treatment.

The technology is FDA approved for Carpal Tunnel Syndrome and Arthritis. Well-known universities and private medical research facilities are currently investigating other applications for the technology.

This technology has other applications such as wound care and general pain management.

The company is currently directing its marketing toward Fitness facilities and Corporate Wellness facilities as over 80 million people suffering from some type of pain ailment. The current market potential for these products and treatments is in the $10-15 billion range.

Neogenex has rights to the purchase and utilization of the patents on this technology.

About Bederra Corp.

http://www.bederra.com

Bederra Corporation, through its wholly owned subsidiaries Lumar Imaging, Inc., Reliant Medical Group and Diagnos, Inc., provides multiple modality diagnostic medical imaging services to the greater Houston area and the world famous Texas Medical Center. The Company's business strategy is to continue to expand its current operations and seek out additional acquisitions that will complement its core offerings.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information